Authors reply: "Seven days versus extended duration antibiotic therapy for multidrug-resistant gram-negative bacterial infections in critically ill patients: A pooled analysis of the OPTIMISE and REGARD-VAP trials".

Umer M, Jagra AS, Hanif FM, Khan M, Sharma H

Open source

DOI
10.1016/j.jcrc.2026.155586
Published
2026 Aug
Container
Journal of critical care
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jcrc.2026.155586,
  title = {Authors reply: "Seven days versus extended duration antibiotic therapy for multidrug-resistant gram-negative bacterial infections in critically ill patients: A pooled analysis of the OPTIMISE and REGARD-VAP trials".},
  author = {Umer M and Jagra AS and Hanif FM and Khan M and Sharma H},
  year = {2026},
  journal = {Journal of critical care},
  doi = {10.1016/j.jcrc.2026.155586},
  url = {https://doi.org/10.1016/j.jcrc.2026.155586}
}

RIS

TY  - JOUR
TI  - Authors reply: "Seven days versus extended duration antibiotic therapy for multidrug-resistant gram-negative bacterial infections in critically ill patients: A pooled analysis of the OPTIMISE and REGARD-VAP trials".
AU  - Umer M
AU  - Jagra AS
AU  - Hanif FM
AU  - Khan M
AU  - Sharma H
PY  - 2026
JO  - Journal of critical care
DO  - 10.1016/j.jcrc.2026.155586
UR  - https://doi.org/10.1016/j.jcrc.2026.155586
ER  - 

APA

M, U., AS, J., FM, H., M, K., & H, S. (2026). Authors reply: "Seven days versus extended duration antibiotic therapy for multidrug-resistant gram-negative bacterial infections in critically ill patients: A pooled analysis of the OPTIMISE and REGARD-VAP trials".. Journal of critical care. https://doi.org/10.1016/j.jcrc.2026.155586

Source records